Heather Phillips - Nanalysis Scientific Director Operations
| NSCIF Stock | USD 0.23 0.02 9.52% |
Insider
Heather Phillips is Director Operations of Nanalysis Scientific Corp
| Phone | 403 769 9499 |
| Web | https://www.nanalysis.com |
Nanalysis Scientific Management Efficiency
The company has return on total asset (ROA) of (0.0726) % which means that it has lost $0.0726 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.197) %, meaning that it generated substantial loss on money invested by shareholders. Nanalysis Scientific's management efficiency ratios could be used to measure how well Nanalysis Scientific manages its routine affairs as well as how well it operates its assets and liabilities.Nanalysis Scientific Corp has accumulated 2.75 M in total debt with debt to equity ratio (D/E) of 0.16, which may suggest the company is not taking enough advantage from borrowing. Nanalysis Scientific Corp has a current ratio of 1.9, which is within standard range for the sector. Debt can assist Nanalysis Scientific until it has trouble settling it off, either with new capital or with free cash flow. So, Nanalysis Scientific's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Nanalysis Scientific Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Nanalysis to invest in growth at high rates of return. When we think about Nanalysis Scientific's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Steven Kent | Know Labs | N/A | |
| Garrett Krushefski | Mesa Laboratories | N/A | |
| MD Anderson | Know Labs | N/A | |
| Peter Dansky | Mesa Laboratories | 63 | |
| Hans Lidforrs | Sensata Technologies Holding | 56 | |
| Lynne Caljouw | Sensata Technologies Holding | 50 | |
| Peter Conley | Know Labs | N/A | |
| Ronald JD | Know Labs | 81 | |
| Moya PEng | Kraken Robotics | N/A | |
| Yann Etienvre | Sensata Technologies Holding | 47 | |
| Dennis Walsh | Genasys | N/A | |
| Daniel Greunes | Scientific Industries | 35 | |
| Daniel Black | Sensata Technologies Holding | 60 | |
| David PEng | Kraken Robotics | N/A | |
| Deborah Boniske | ESCO Technologies | N/A | |
| Richard Danforth | Genasys | 65 | |
| Phillip Bosua | Know Labs | 50 | |
| Sarah Betadam | Novanta | N/A | |
| Bruce Butler | ESCO Technologies | 64 | |
| Leonardo Troutwein | Know Labs | N/A | |
| Juan Picon | Sensata Technologies Holding | 54 | |
Management Performance
| Return On Equity | -0.2 | |||
| Return On Asset | -0.0726 |
Nanalysis Scientific Corp Leadership Team
Elected by the shareholders, the Nanalysis Scientific's board of directors comprises two types of representatives: Nanalysis Scientific inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Nanalysis. The board's role is to monitor Nanalysis Scientific's management team and ensure that shareholders' interests are well served. Nanalysis Scientific's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Nanalysis Scientific's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Susanne Riegel, Director Mang | ||
| Sean MSc, CEO, Founder | ||
| Julien Muller, Chief Officer | ||
| Greg McFeetors, Head Manufacturing | ||
| Heather Phillips, Director Operations | ||
| Matt Zamora, Sales Mang | ||
| Matthew Selinger, Investor Mang |
Nanalysis Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Nanalysis Scientific a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.2 | |||
| Return On Asset | -0.0726 | |||
| Profit Margin | (0.30) % | |||
| Operating Margin | (0.28) % | |||
| Current Valuation | 52.82 M | |||
| Shares Outstanding | 94.22 M | |||
| Shares Owned By Insiders | 7.37 % | |||
| Shares Owned By Institutions | 0.09 % | |||
| Price To Book | 1.91 X | |||
| Price To Sales | 2.30 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Nanalysis OTC Stock
Nanalysis Scientific financial ratios help investors to determine whether Nanalysis OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nanalysis with respect to the benefits of owning Nanalysis Scientific security.